Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT04605094 · TERMINATED
Trial details
- NCT number
- NCT04605094
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-12
- Primary completion
- 2022-04-25
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.